Date A, John G T, Thomas P P, Jacob C K
Department of Pathology, Christian Medical College & Hospital, Vellore, India.
Lepr Rev. 1998 Mar;69(1):40-5. doi: 10.5935/0305-7518.19980005.
Nine cases of leprosy in patients treated at a large renal transplant centre in South Asia are described. Three had leprosy diagnosed before transplantation and had either completed or were continuing chemotherapy at the time of transplantation. One showed exacerbation of undisclosed leprosy after transplantation. Five patients developed the disease for the first time 22 months to 12 years after transplantation. Immunosuppression did not adversely affect the treatment of leprosy in any of the patients though concurrent liver disease required cessation of rifampicin in one patient.
本文描述了在南亚一家大型肾移植中心接受治疗的9例麻风病患者。其中3例在移植前被诊断为麻风病,在移植时已完成或正在进行化疗。1例在移植后出现未公开的麻风病病情加重。5例患者在移植后22个月至12年首次患上该病。免疫抑制对任何患者的麻风病治疗均未产生不利影响,尽管1例患者因并发肝病需要停用利福平。